logo

For the Inventor, By the Inventor

Hanover, Germany

Abbott Products Gmbh


USPTO Granted Patents = 17

% Expired Patents = 70.6



Trademarks = 5

Forward Citations = 6

Loading Chart...
Loading Chart...

62 inventors (with patents filed for the assignee):

goldMedal Pasi Koskimies (4 out of 15 patents)

silverMedal Bernd Thumbeck (4 out of 5 patents)

bronzeMedal Heinrich-Hubert Thole (4 out of 7 patents)

4.  Josef Messinger (4 out of 14 patents)

5.  Bettina Husen (4 out of 6 patents)

6.  Uwe Schoen (3 out of 22 patents)

7.  Michael Weske (3 out of 15 patents)

8.  George Shlieout (2 out of 4 patents)

9.  Dachun Liu (2 out of 39 patents)

10.  William A Carroll (2 out of 59 patents)

11.  Clarence J Maring (2 out of 35 patents)

12.  Michael D Tufano (2 out of 24 patents)

13.  David A Betebenner (2 out of 38 patents)

14.  Douglas K Hutchinson (2 out of 37 patents)

15.  Axel Pahl (2 out of 8 patents)


17 patents:

1. 10072256 - Process for separating and determining the viral load in a pancreatin sample (2018-09-11),
2. 9567355 - Hepatitis C inhibitors and uses thereof (2017-02-14),
3. 9453007 - Hepatitis C inhibitors and uses thereof (2016-09-27),
4. 9198871 - Delayed release pancreatin compositions (2015-12-01),
5. 8815299 - Method for obtaining a natural mixture of conjugated equine estrogens depleted in non-conjugated lipophilic compounds (2014-08-26),
6. 8802087 - Pharmaceutical compositions of lipase-containing products, in particular of pancreation (2014-08-12),
7. 8435973 - 17-beta HSD1 and STS inhibitors (2013-05-07),
8. 8329679 - Preformulation for tabletting natural mixtures of conjugated estrogens (2012-12-11),
9. 8273905 - [object Object] (2012-09-25),
10. 8273728 - Preformulation for tabletting natural mixtures of conjugated estrogens (2012-09-25),
11. 8268351 - Matrix film tablet with controlled release of a natural mixture of conjugated estrogens (2012-09-18),
12. 8114906 - Essential fatty acids in the treatment and/or inhibition of depression in patients with coronary heart or artery disease (2012-02-14),
13. 8088758 - 17β-hydroxysteroid dehydrogenase type I inhibitors (2012-01-03),
14. 8080540 - Therapeutically active triazoles and their use (2011-12-20),
15. 8058264 - Pharmaceutical compositions comprising CB1 cannabinoid receptor antagonists and potassium channel openers for the treatment of obesity and related conditions (2011-11-15),
Company Overview
Abbott Products GmbH, based in Hanover, Germany, is a subsidiary of Abbott Laboratories, a global healthcare company. The organization specializes in the development and manufacturing of a diverse range of medical devices, diagnostics, nutrition products, and pharmaceuticals. With a commitment to innovation, Abbott focuses on enhancing patient care through advanced technologies and solutions. Its research and development efforts span various domains, including cardiovascular health, diabetes management, and nutritional science, contributing to improved health outcomes worldwide.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

17 Patents

#48 in Hanover

#2,495 in Germany

#35,918 in the World

Hanover, DE
Hanover, Germany

Abbott Products Gmbh

Forward Citations = 6

62 inventors:

goldMedal Pasi Koskimies (4 out of 15 patents)

silverMedal Bernd Thumbeck (4 out of 5 patents)

bronzeMedal Heinrich-Hubert Thole (4 out of 7 patents)

4.  Josef Messinger (4 out of 14 patents)

5.  Bettina Husen (4 out of 6 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Abbott Products Gmbh. Retrieved from https://idiyas.com/company/abbott-products

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…